Neda Bakalova

Dr. Neda Bakalova

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2019
Verified
Report
Closed access
FAFilip Abedinov
Filip Abedinov
NBNeda Bakalova
Neda Bakalova
PKPlamen Krastev
Plamen Krastev
IPIliyan Petrov
Iliyan Petrov
RMRalitza Marinova
Ralitza Marinova
GTGeorgy Tsaryanski
Georgy Tsaryanski

21 December 2019
Verified
Report
Closed access
FAFilip Abedinov
Filip Abedinov
PKPlamen Krastev
Plamen Krastev
RMRalitza Marinova
Ralitza Marinova
IPIliyan Petrov
Iliyan Petrov
NBNeda Bakalova
Neda Bakalova
HAHristo Angelov
Hristo Angelov

30 April 2023 in Proceedings of the Bulgarian Academy of Sciences
Verified
Journal Article
Closed access
RERostislav Enev
Rostislav Enev
FAFillip Abedinov
Fillip Abedinov
NBNeda Bakalova
Neda Bakalova
MAMargarita Atanasova
Margarita Atanasova
NCNezabravka Chilingirova
Nezabravka Chilingirova
PKPlamen Krastev
Plamen Krastev

17 December 2021 in medRxiv
Verified
Preprint
Open access
PDF file
NBNeda Bakalova
Neda Bakalova
INIvats Natsev
Ivats Natsev
HDHristo Damov
Hristo Damov
IYIrina Yatsenko
Irina Yatsenko
SJStefanija Jovinska
Stefanija Jovinska
DKDenitza Kalendjieva
Denitza Kalendjieva
Background: The first surge of coronavirus disease 2019 (COVID-19) cases in Bulgaria occurred in the fall of 2020. Here we describe the clinical presentation, patient characteristics, treatments and outcomes of mechanically ventilated COVID-19 patients in a newly formed COVID-19 ICU at a tertiary cardiac center in Sofia, Bulgaria. Methods: This is a retrospective observational study of mechanically ventilated COVID-19 patients admitted to Sveta Ekaterina University Hospital in Sofia, Bulgaria, between November 4th, 2020 and January 6th, 2021. Data were collected from electronic and written patient records and charts. Results: We identified 38 critical care patients admitted with respiratory failure and treated with mechanical ventilation at our COVID-19 ICU during this period. The median age was 66 (IQR 57-76, range 27-89) and 74% were male. Most patients, 36 (95%), had at least one comorbidity. The most common comorbidities were hypertension, valvular heart disease, ischemic heart disease and diabetes mellitus. Overall, 27 (71%) patients had a concomitant cardiac disease other than hypertension and 24% were recent cardiac surgical patients. Inotropic support was required in 29 (76%) patients, renal replacement therapy in 12 (32%) patients and prone positioning and ECMO were used in 5 (13%) and 2 (5%) patients respectively. The median duration of mechanical ventilation was 7.5 (IQR 5-14) days overall and 9 (IQR 6-13) days for survivors. At 30-days 28 (74%) of patients had died. Overall, 32 (84%) patients died in hospital and only 6 (16%) patients were discharged home. Conclusions: During the first major surge of COVID-19 cases in Bulgaria, despite the wave arriving later than in other countries, the healthcare system was largely unprepared. In our setting, mortality in mechanically ventilated patients was very high at 84%. Several factors might have contributed to these results, namely the predominance of cardiovascular comorbidities in our patient population, the strained ICU capacity and the lack of medical personnel.